123 related articles for article (PubMed ID: 33612758)
1. Novel Piperine compound AB05 (N-5-(3,4-dimethoxyphenyl) -2E,4E pentadienylpiperidine) inhibits H1N1 influenza virus propagation in vitro.
Mohammed A; Velu AB; Al-Hakami AM; Meenakshisundaram B; Esther P; Abdelwahid SA; Irfan A; Prasanna R; Anantharam D; Harish CC
Trop Biomed; 2020 Dec; 37(4):1062-1073. PubMed ID: 33612758
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase.
Ding Y; Dou J; Teng Z; Yu J; Wang T; Lu N; Wang H; Zhou C
Arch Virol; 2014 Dec; 159(12):3269-78. PubMed ID: 25078390
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of furanocoumarins isolated from Angelica dahurica against influenza a viruses H1N1 and H9N2.
Lee BW; Ha TKQ; Cho HM; An JP; Kim SK; Kim CS; Kim E; Oh WK
J Ethnopharmacol; 2020 Sep; 259():112945. PubMed ID: 32389854
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activity of puerarin as potent inhibitor of influenza virus neuraminidase.
Wang HX; Zeng MS; Ye Y; Liu JY; Xu PP
Phytother Res; 2021 Jan; 35(1):324-336. PubMed ID: 32757226
[TBL] [Abstract][Full Text] [Related]
5. A Novel Natural Influenza A H1N1 Virus Neuraminidase Inhibitory Peptide Derived from Cod Skin Hydrolysates and Its Antiviral Mechanism.
Li J; Chen Y; Yuan N; Zeng M; Zhao Y; Yu R; Liu Z; Wu H; Dong S
Mar Drugs; 2018 Oct; 16(10):. PubMed ID: 30308963
[TBL] [Abstract][Full Text] [Related]
6.
Lloren KKS; Kwon JJ; Choi WS; Jeong JH; Ahn SJ; Choi YK; Baek YH; Song MS
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602610
[TBL] [Abstract][Full Text] [Related]
7. Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza.
Huang CT; Hung CY; Hseih YC; Chang CS; Velu AB; He YC; Huang YL; Chen TA; Chen TC; Lin CY; Lin YC; Shih SR; Dutta A
Phytomedicine; 2019 Nov; 64():152904. PubMed ID: 31454654
[TBL] [Abstract][Full Text] [Related]
8. An I436N substitution confers resistance of influenza A(H1N1)pdm09 viruses to multiple neuraminidase inhibitors without affecting viral fitness.
Kwon JJ; Choi WS; Jeong JH; Kim EH; Lee OJ; Yoon SW; Hwang J; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
J Gen Virol; 2018 Mar; 99(3):292-302. PubMed ID: 29493493
[TBL] [Abstract][Full Text] [Related]
9. Design, in silico studies, synthesis and in vitro evaluation of oseltamivir derivatives as inhibitors of neuraminidase from influenza A virus H1N1.
Neri-Bazán RM; García-Machorro J; Méndez-Luna D; Tolentino-López LE; Martínez-Ramos F; Padilla-Martínez II; Aguilar-Faisal L; Soriano-Ursúa MA; Trujillo-Ferrara JG; Fragoso-Vázquez MJ; Barrón BL; Correa-Basurto J
Eur J Med Chem; 2017 Mar; 128():154-167. PubMed ID: 28182988
[TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of synergistic inhibitory effects of neuraminidase inhibitors and methylglyoxal against influenza virus infection.
Charyasriwong S; Watanabe K; Rahmasari R; Matsunaga A; Haruyama T; Kobayashi N
Arch Med Res; 2015 Jan; 46(1):8-16. PubMed ID: 25523147
[TBL] [Abstract][Full Text] [Related]
11. Cirsimaritin inhibits influenza A virus replication by downregulating the NF-κB signal transduction pathway.
Yan H; Wang H; Ma L; Ma X; Yin J; Wu S; Huang H; Li Y
Virol J; 2018 May; 15(1):88. PubMed ID: 29783993
[TBL] [Abstract][Full Text] [Related]
12. Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010-2015.
Tewawong N; Marathe BM; Poovorawan Y; Vongpunsawad S; Webby RJ; Govorkova EA
PLoS One; 2018; 13(1):e0190877. PubMed ID: 29324781
[TBL] [Abstract][Full Text] [Related]
13. 3D-quantitative structure-activity relationship and antiviral effects of curcumin derivatives as potent inhibitors of influenza H1N1 neuraminidase.
Lai Y; Yan Y; Liao S; Li Y; Ye Y; Liu N; Zhao F; Xu P
Arch Pharm Res; 2020 May; 43(5):489-502. PubMed ID: 32248350
[TBL] [Abstract][Full Text] [Related]
14. Oroxylin A suppresses influenza A virus replication correlating with neuraminidase inhibition and induction of IFNs.
Jin J; Chen S; Wang D; Chen Y; Wang Y; Guo M; Zhou C; Dou J
Biomed Pharmacother; 2018 Jan; 97():385-394. PubMed ID: 29091888
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of a synthesized shikonin ester against influenza A (H1N1) virus and insights into its mechanism.
Zhang Y; Han H; Qiu H; Lin H; Yu L; Zhu W; Qi J; Yang R; Pang Y; Wang X; Lu G; Yang Y
Biomed Pharmacother; 2017 Sep; 93():636-645. PubMed ID: 28688289
[TBL] [Abstract][Full Text] [Related]
16. Flavonoids from Matteuccia struthiopteris and Their Anti-influenza Virus (H1N1) Activity.
Li B; Ni Y; Zhu LJ; Wu FB; Yan F; Zhang X; Yao XS
J Nat Prod; 2015 May; 78(5):987-95. PubMed ID: 25927664
[TBL] [Abstract][Full Text] [Related]
17. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012-2013 season.
Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
J Infect Chemother; 2015 Jan; 21(1):39-42. PubMed ID: 25277670
[TBL] [Abstract][Full Text] [Related]
18. Passaging of an influenza A(H1N1)pdm09 virus in a difluoro sialic acid inhibitor selects for a novel, but unfit I106M neuraminidase mutant.
McKimm-Breschkin JL; Barrett S; McKenzie-Kludas C; McAuley J; Streltsov VA; Withers SG
Antiviral Res; 2019 Sep; 169():104542. PubMed ID: 31233807
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the anti-neuraminidase activity of the traditional Chinese medicines and determination of the anti-influenza A virus effects of the neuraminidase inhibitory TCMs in vitro and in vivo.
Tian L; Wang Z; Wu H; Wang S; Wang Y; Wang Y; Xu J; Wang L; Qi F; Fang M; Yu D; Fang X
J Ethnopharmacol; 2011 Sep; 137(1):534-42. PubMed ID: 21699971
[TBL] [Abstract][Full Text] [Related]
20. A plausible explanation for enhanced bioavailability of P-gp substrates in presence of piperine: simulation for next generation of P-gp inhibitors.
Singh DV; Godbole MM; Misra K
J Mol Model; 2013 Jan; 19(1):227-38. PubMed ID: 22864626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
